Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
5-Amino-1MQ
Weight Management
Abarelix
Hormone Support
Acetyl Hexapeptide-3 (Argireline)
Cosmetic
Adipotide
Weight Management
Adrenomedullin
Healing & Recovery
Alexamorelin
Growth Hormone
Angiotensin (1-7)
Healing & Recovery
AOD-9604
Weight Management
Apelin-13
Healing & Recovery
ARA-290 (Cibinetide)
Healing & Recovery
Bestatin (Ubenimex)
Immune
BPC-157
Healing & Recovery
Buserelin
Hormone Support
Cagrilintide
Weight Management
CagriSema
Weight Management
Capromorelin
Growth Hormone
Cartalax
Anti-Aging
Cathelicidin (hCAP-18 / Synthetic Derivatives)
Immune
Cerebrolysin
Cognitive
Cerluten
Cognitive
Cetrorelix
Hormone Support
Chonluten
Immune
CJC-1295 (No DAC)
Growth Hormone
CJC-1295 with DAC
Growth Hormone
Cortexin
Cognitive
Crystagen
Immune
Daptomycin
Immune
Defensin (HBD-2)
Immune
Defensin (HBD-3)
Immune
Degarelix
Hormone Support
Dihexa
Cognitive
DSIP (Delta Sleep-Inducing Peptide)
Sleep & Recovery
Dulaglutide
Weight Management
Enalapril
Healing & Recovery
Epithalon
Anti-Aging
Exenatide
Weight Management
Fertirelin
Hormone Support
FOXO4-DRI
Anti-Aging
Ganirelix
Hormone Support
GHK-Cu (Copper Peptide)
Cosmetic
GHRH (1-29)
Growth Hormone
GHRP-2
Growth Hormone
GHRP-6 (Growth Hormone Releasing Peptide-6)
Growth Hormone
Glutathione
Anti-Aging
Gonadorelin (GnRH)
Hormone Support
Gramicidin
Immune
Hexarelin
Growth Hormone
Human Chorionic Gonadotropin (HCG)
Hormone Support
Human Growth Hormone (HGH)
Growth Hormone
IGF-1 LR3
Growth Hormone
Immunoxel (Dzherelo)
Immune
Imunofan
Immune
Intermedin (Adrenomedullin-2)
Healing & Recovery
Ipamorelin
Growth Hormone
Kisspeptin-10
Sexual Health
KPV (Alpha-MSH Fragment)
Healing & Recovery
Lactoferricin B
Immune
Larazotide
Healing & Recovery
Lentinan
Immune
Leuphasyl
Cosmetic
Leuprolide
Hormone Support
Liraglutide
Weight Management
Livagen
Anti-Aging
Lixisenatide
Weight Management
LL-37
Immune
Macimorelin
Growth Hormone
Magainin-2
Immune
Mazdutide
Weight Management
Melanotan-2
Cosmetic
MK-677 (Ibutamoren)
Growth Hormone
MOTS-c
Metabolic
Myristoyl Pentapeptide-17
Cosmetic
N-Acetyl Selank
Cognitive
N-Acetyl Semax Amidate
Cognitive
NAD+
Mitochondrial
Nafarelin
Hormone Support
Natriuretic Peptide (ANP)
Healing & Recovery
Nesiritide (BNP)
Healing & Recovery
Nisin
Immune
Noopept (Omberacetam)
Cognitive
Orforglipron
Weight Management
Ovagen
Anti-Aging
Oxytocin Acetate
Hormone Support
P21 (P021)
Cognitive
PACAP-38
Healing & Recovery
Palmitoyl Oligopeptide
Cosmetic
Palmitoyl Pentapeptide-4 (Matrixyl)
Cosmetic
Palmitoyl Tetrapeptide-7
Cosmetic
Palmitoyl Tripeptide-1
Cosmetic
Pancragen
Metabolic
PEG-MGF
Healing & Recovery
Pemvidutide
Weight Management
Pentadecapeptide (BPC Analog)
Healing & Recovery
Pidotimod
Immune
Pinealon
Cognitive
PNC-27
Immune
Polymyxin B
Immune
Pralmorelin (GHRP-2)
Growth Hormone
Pramlintide
Weight Management
Prostamax
Hormone Support
PT-141 (Bremelanotide)
Sexual Health
Relaxin-2 (Serelaxin)
Healing & Recovery
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Setmelanotide
Weight Management
SLU-PP-332
Metabolic
SM-130686
Growth Hormone
Snap-8
Cosmetic
SS-31 (Elamipretide)
Mitochondrial
Substance P Antagonists
Healing & Recovery
Survodutide
Weight Management
SYN-AKE
Cosmetic
Tabimorelin
Growth Hormone
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Testagen
Hormone Support
Thymalin
Immune
Thymopentin (TP-5)
Immune
Thymopoietin
Immune
Thymosin Alpha-1
Immune
Thymosin Beta-4
Healing & Recovery
Thymulin (FTS)
Immune
Thymulin Analog (PAT)
Healing & Recovery
Tirzepatide
Weight Management
Tripeptide-29
Cosmetic
Triptorelin
Hormone Support
Ularitide
Healing & Recovery
Urocortin
Healing & Recovery
Ventfort
Anti-Aging
Vesilute
Hormone Support
Vilon
Immune
VIP (Vasoactive Intestinal Peptide)
Healing & Recovery
Xenin-25
Metabolic
Ziconotide (Prialt)
Healing & Recovery
Total Peptides: 137
Back to Home
Back to Ganirelix

Clinical trials

Every registered trial of Ganirelix

97 studies, 9 still enrolling.

Plain-Language Summary

Plain-language reading of the public trial registries.

In short

  • Ganirelix has a real but limited body of human research.
  • 97 registered studies in total.
  • 9 are still enrolling people, so this is active research, not just history.

What kind of research

  • 82 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
  • About 15,296 people took part in those.
  • A further 15 studies only looked at records of people already taking it. These are counted separately because nobody was given the peptide for the study, so they cannot prove cause and effect.

How far along it is

  • 45 trials have reached phase 3 or 4 — the large, late-stage trials regulators rely on to approve a drug.
  • 24 have published results in the medical literature that anyone can read.
  • The research spans 21 countries.

A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.

Filter

Showing 97 of 97 trials for Ganirelix.

  • NCT06877429Not Yet Recruiting20 enrolled2026

    Is the Diurnal Variation in Circulating Levels of Cortisol Reflected in Follicular Fluid of Preovulatory Follicles Close to Ovulation?

    ART Fertility Clinics LLC

    Healthy

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT07409493Recruiting148 enrolled2026

    IVF Outcomes With Time-Lapse Culture: Comparison Between PPOS and GnRH Antagonist Protocols

    Hanoi Medical University

    Infertility (IVF Patients) · Embryo Morphokinetics · Progestins Primed Ovarian Stimulation

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT07108621Phase 3Recruiting80 enrolled2025

    hCG Priming in Women With Diminished Ovarian Reserve

    Kristine Loessl

    Infertility, Female · Ovarian Reserve · In Vitro Fertilization (IVF)

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06175832Phase 4Recruiting60 enrolled2025

    PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study

    University Hospital, Ghent

    Ovarian Stimulation · Quality of Life · Preimplantation Genetic Testing · Fertility Preservation

  • 2023-506694-35-00Ongoing60 enrolled2025

    P-CCROSS

    Universitair Ziekenhuis Gent

    Subfertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • 2023-508769-33-00Ongoing144 enrolled2024

    Protocol with Progestin-primed Ovarian Stimulation (PPOS) in conventional treatment from the start of stimulation vs protocol with GnRH antagonists as a pituitary suppressor in patients who are going to undergo DUOSTIM with embryo accumulation for PGT-A of the embryos.

    Ginefiv S.L.

    Female infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06745466Phase 4Recruiting30 enrolled2024

    Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerated Vascular Aging in Midlife Women

    University of Delaware

    Estrogen · Premenopause

  • NCT06637189Phase 4Not Yet Recruiting144 enrolled2024

    Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.

    Ginefiv

    Stimulation in the Ovary · Embryo · Oocyte · Oocyte Retrieval

  • NCT06481696Unknown90 enrolled2024

    Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility

    Andros Day Surgery Clinic

    Unexplained Infertility

  • NCT05751252Early Phase 1Completed20 enrolled2024

    Sub-therapeutic GnRH- Antagonist Treatment to Rectify LH Pulsatility in Lean Women With PCOS.

    University Hospital, Lille

    Polycystic Ovary Syndrome

  • 2024-514102-32-00Revoked20 enrolled2024

    2022_0016

    Centre Hospitalier Universitaire De Lille

    Polycystic ovarian

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06280560Recruiting60 enrolled2024

    Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation

    Fundación IVI

    Endometrial Receptivity

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05954962Phase 4Completed150 enrolled2023

    Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation.

    Instituto Bernabeu

    IVF

  • NCT05994378Phase 3Completed317 enrolled2023

    To Compare the Efficacy and Safety of Oral SHR 7280 Tablets With Ganirelix Acetate Injection in Infertile Female Subjects

    Jiangsu HengRui Medicine Co., Ltd.

    Infertile Female Subjects Undergoing Controlled Ovarian Hyperstimulation to Suppress Premature LH Surge and Prevent Early Ovulation

  • NCT05847283Recruiting730 enrolled2023

    DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Reserve Patients: An RCT

    Tam Anh TP. Ho Chi Minh General Hospital

    Diminished Ovarian Reserve

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06091436Phase 3Completed176 enrolled2023

    To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference

    Changchun GeneScience Pharmaceutical Co., Ltd.

    Infertility

  • 2023-509094-23-00Ongoing300 enrolled2022

    MONACO

    Universitair Ziekenhuis Gent

    Subfertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04993924Phase 4Unknown15 enrolled2021

    GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst

    Assaf-Harofeh Medical Center

    IVF · Ovarian Cysts

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05071339Phase 4Unknown15 enrolled2021

    GnRH Antagonist Pre-treatment for the Prevention of Asynchronous Follicular Growth

    Assaf-Harofeh Medical Center

    IVF

  • NCT04643925Phase 4Completed20 enrolled2020

    hCG Priming in Women With Low Ovarian Reserve

    Rigshospitalet, Denmark

    Infertility, Female · Ovarian Reserve · In Vitro Fertilization

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04728659Phase 4Unknown165 enrolled2020

    Desogestrel Versus GnRH Antagonist in IVF/ICSI

    Casa di Cura Privata Villa Mafalda

    IVF · Infertility

  • NCT04654741Phase 4Unknown396 enrolled2020

    The Rate of Embryo Euploidy in Progestin-primed Ovarian Stimulation Cycles

    Casa di Cura Privata Villa Mafalda

    IVF · Infertility

  • NCT04414761Phase 3Completed784 enrolled2020

    Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response

    ShangHai Ji Ai Genetics & IVF Institute

    IVF · GnRH Antagonist · PPOS

  • NCT04037605Early Phase 1Active Not Recruiting5 enrolled2020

    Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women

    Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

    Sleep Restriction

  • NCT04166825Recruiting300 enrolled2019

    Ovarian Hyperstimulation and Fibrin Clot Properties.

    Jagiellonian University

    Fibrin Blood Clot · Infertility, Female · Endometriosis

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04168892Completed160 enrolled2019

    Anti-Müllerian Hormone (AMH) Measured With Fully Automated Assay Versus AFC in the Prediction of Ovarian Response

    Andros Day Surgery Clinic

    Ovarian Response

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT03767218Phase 3Completed71 enrolled2018

    Initiation of Ovarian Stimulation With Recombinant-human FSH (Bemfola®) in the Late Follicular Phase

    Universitair Ziekenhuis Brussel

    Infertility, Female

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04416607Completed300 enrolled2018

    Corifollitropin Alpha and Ovarian Response

    Hospital de Clinicas de Porto Alegre

    Infertility, Female

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT03555942Completed44 enrolled2018

    Luteal Phase-start Ovarian Stimulation With Corifollitropin Alfa

    Fundacion Dexeus

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02912988Phase 3Completed900 enrolled2018

    Letrozole in Stimulated IVF Cycles

    The University of Hong Kong

    Subfertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT03291821Completed136 enrolled2017

    DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore

    IVI Madrid

    Infertility, Female

  • NCT04327934Early Phase 1Terminated28 enrolled2017

    Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome

    Yale University

    Polycystic Ovary Syndrome · Hypertension

  • NCT03300518Completed552 enrolled2017

    Effectiveness of Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response Patient

    Reproductive & Genetic Hospital of CITIC-Xiangya

    Infertility

  • NCT03477929Phase 4Unknown100 enrolled2017

    Cetrorelix and Ganirelix Flexible Protocol for (IVF)

    Università degli Studi 'G. d'Annunzio' Chieti e Pescara

    Infertility/Sterility

  • NCT03300960Phase 3Completed318 enrolled2017

    Usefulness of Medroxyprogesterone Acetate in Follicular Phase in Oocyte Donors. Undergoing Ovarian Stimulation

    Instituto Valenciano de Infertilidad, IVI VALENCIA

    Infertility

  • NCT03142893Phase 1Active Not Recruiting80 enrolled2017

    Hormonal Mechanisms of Sleep Restriction - Axis Study

    Peter y. Liu

    Sleep Restriction

  • NCT03861715Unknown180 enrolled2017

    Single Follicular Dexarelix for LH Suppression During Ovarian Stimulation in Oocyte Donors.

    Assisting Nature

    Infertility · Premature Ovarian Failure

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT03051087Phase 4Completed255 enrolled2016

    To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran®

    LG Life Sciences

    Controlled Ovarian Stimulation

  • NCT03236545Completed48 enrolled2016

    Menopause Effects on Vascular Function

    University of Delaware

    Cardiovascular Risk Factor

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02796105Phase 4Completed232 enrolled2016

    Progevera 10 mg® Versus Orgalutran® in Ovarian Stimulation Cycles of Oocyte Donors

    Fundació Privada Eugin

    Infertility

  • NCT02635607Unknown200 enrolled2016

    Effectiveness and Safety Study of Fixed Versus Flexible of Gonadotropin-releasing Hormone Antagonist Protocol

    Chong Qing Reproducive and Genetic Institute

    Infertility

  • NCT02402192Phase 4Terminated201 enrolled2015

    Type of Gonadotropin and Embryo Kinetics of Development

    IVI Madrid

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02429999Phase 2Unknown80 enrolled2015

    Letrozole in Assisted Reproductive Technology

    Assiut University

    to Evaluate Letrozole as a Modality for Minimal Ovarian Stimulation in ICSI Cycles .

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02069808Phase 4Completed38 enrolled2014

    Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation

    Michigan Reproductive Medicine

    Egg Donation

  • NCT01599494Phase 3Withdrawn2014

    An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)

    Organon and Co

    Infertility

  • NCT02118051Phase 3Completed234 enrolled2013

    Effect of Treatment With Corifollitropin Alpha in Vitro Fertilization in Patients With Poor Ovarian Response.

    Instituto de Investigacion Sanitaria La Fe

    Infertility

  • NCT01816321Phase 3Completed150 enrolled2013

    Corifollitropin Alfa Followed by Menotropin for Poor Ovarian Responders Trial

    Universitair Ziekenhuis Brussel

    Infertility · Poor Ovarian Response

  • NCT01636505Phase 3Unknown200 enrolled2012

    The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation Protocol

    European Hospital

    Embryo's Genetic and Chromosomal Quality

  • NCT01645241Completed15 enrolled2012

    Evolutive Potential of Embryos Obtained From Oocytes After Luteal Phase Ovarian Stimulation

    Fundacion Dexeus

    INFERTILITY · Fertility Preservation · Ovulation Induction · Vitrification

  • NCT01669291Completed43 enrolled2012

    Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation

    Main Line Fertility Center

    Fertility

  • NCT01614067Phase 4Terminated30 enrolled2012

    Delayed Start to Ovarian Stimulation

    University of California, San Francisco

    Diminished Ovarian Reserve · Infertility · In Vitro Fertilization

  • NCT01487486Unknown30 enrolled2011

    Proteomics & Glyco-Proteomic Analysis of Follicular Fluid

    University of Cincinnati

    Polycystic Ovary Syndrome · Normal Volunteers

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01286051Completed80 enrolled2011

    Single Injection of Ganirelix in Gonadotropin Intrauterine Insemination (IUI) Cycles

    Houston Fertility Institute

    Compare Pregnancy Rates Between FSH Stimulation and FSH and · GnRH Antagonist

  • NCT02046655Phase 4Completed80 enrolled2011

    Corifollitropin Alfa Compared to Daily rFSH in Poor Responders Undergoing ICSI

    Aristotle University Of Thessaloniki

    Subfertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01255397Unknown50 enrolled2011

    Proposed Research Protocol For Male Infertility

    HaEmek Medical Center, Israel

    Male Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01206803Completed294 enrolled2010

    Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients

    University Hospital Schleswig-Holstein

    Infertility, Subfertility

  • NCT01888744Phase 4Completed120 enrolled2010

    Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist

    Universitair Ziekenhuis Brussel

    Reproductive Endocrinology · Fertility · Optimal Stimulation Protocol

  • NCT01218386Phase 4Completed80 enrolled2010

    Pretreatment With Estradiol Valerate

    Universitair Ziekenhuis Brussel

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01385332Completed10 enrolled2010

    A Comparative Study of Two Patterns of Controlled Ovarian Hyperstimulation in Mid Follicular Phase or Early Luteal Phase for Egg Donors

    Parc de Salut Mar

    Stimulation in the Ovary

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • ISRCTN02750360194 enrolled2009

    An additional rescue dose of GnRH antagonist administered the day before hCG trigger is effective to prevent ovarian hyperstimulation syndrome (OHSS) in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes

    IAKENTRO (Greece)

    Ovarian hyperstimulation syndrome (OHSS), ovarian stimulation, GnRH antagonist, IVF

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • ISRCTN21199799200 enrolled2009

    Metformin and gonadotrophin-releasing hormone (GnRH) antagonist co-treatment in in-vitro fertilisation (IVF) for women with polycystic ovary syndrome (PCOS)

    Leeds Teaching Hospitals NHS Trust (UK)

    Polycystic ovary syndrome

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT00826839Phase 4Withdrawn2009

    Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients

    Weill Medical College of Cornell University

    Infertility

  • NCT00823472Phase 4Terminated147 enrolled2009

    Trial Comparing Start Stimulation of Recombinant Follicle Stimulating Hormone (rFSH) on Cycle Day 2 Versus Cycle Day 5 in In Vitro Fertilization (IVF)

    UMC Utrecht

    in Vitro Fertilization · Ovulation Induction

  • NCT00756028Phase 4Completed1,099 enrolled2009

    Short Versus Long Protocol for IVF and IVF+ICSI

    Peter Hornnes, MD, DMSc

    Infertility · Ovarian Hyperstimulation Syndrome · Quality of Life · Live Birth

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT00802360Phase 4Completed173 enrolled2008

    MENOPUR® Versus FOLLISTIM®

    Ferring Pharmaceuticals

    Infertility

  • NCT00780858Completed662 enrolled2008

    Premature Luteinization Prevention by GnRH Antagonist in Patients Undergoing IUI

    IVI Madrid

    Infertility

  • NCT00866008Phase 4Terminated34 enrolled2008

    A Study of the Effects of a Novel Ovarian Stimulation Regimen on Embryo Aneuploidy Rates in In Vitro Fertilization (IVF)

    Bart CJM Fauser

    In Vitro Fertilization

  • NCT00823004Phase 1/2Completed120 enrolled2008

    Antagonist/Letrozole in Poor Responders

    Yazd Research & Clinical Center for Infertility

    Ovarian Stimulation

  • NCT00823602Phase 3Unknown2 enrolled2008

    Agonist Gonadotropin-Releasing Hormone (GnRH) Versus Antagonist GnRH

    Yazd Research & Clinical Center for Infertility

    Infertility

  • NCT00757185Early Phase 1Completed28 enrolled2008

    Compromised Microcirculation in Women With Polycystic Ovary Syndrome

    Yale University

    Polycystic Ovary Syndrome

  • NCT00830492Phase 4Completed200 enrolled2008

    Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist

    Yazd Research & Clinical Center for Infertility

    Ovarian Stimulation

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT00725491Phase 3Completed259 enrolled2007

    A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703)

    Organon and Co

    Controlled Ovarian Stimulation

  • NCT00702624Completed113 enrolled2007

    Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05690 (Care Program) (P05710)

    Organon and Co

    Pregnancy · Neonates

  • NCT00608062Completed155 enrolled2007

    Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women

    University of Colorado, Denver

    Arterial Stiffening · Aging · Menopause

  • NCT00417157Completed135 enrolled2007

    Modified Natural Cycle Offers a Chance of Pregnancy in Patients With Poor Response and High Basal FSH

    Eugonia

    Infertility · Premature Ovarian Failure

  • NCT00702845Phase 3Completed397 enrolled2006

    To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001)

    Organon and Co

    Infertility

  • NCT00702546Completed102 enrolled2006

    Follow-up Protocol on the Outcome of Frozen-thawed Embryo Transfer Cycles From Clinical Trial P05690 (P05711)

    Organon and Co

    In Vitro Fertilization

  • NCT00703014Completed541 enrolled2006

    Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)

    Organon and Co

    Pregnancy · Neonates

  • NCT00696800Phase 3Completed1,509 enrolled2006

    A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)

    Organon and Co

    In Vitro Fertilization

  • NCT00702273Completed344 enrolled2006

    Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716)

    Organon and Co

    In Vitro Fertilization

  • NCT00734279Early Phase 1Completed11 enrolled2006

    Follicle-Stimulating Hormone (FSH) and the Onset of Puberty

    University of Utah

    Delayed Puberty · Precocious Puberty

  • NCT01153581Phase 2Completed109 enrolled2006

    Sex Hormones and Orthostatic Tolerance

    Yale University

    Orthostatic Intolerance

  • NCT01424618Unknown20 enrolled2006

    A Novel Approach to Endometrial Preparation in Recipients of Donor Eggs

    Kelly, Maureen, M.D.

    Implantation, Embryo

  • NCT00589134Completed26 enrolled2006

    The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration

    Yale University

    Exercise Induced Hyponatremia

  • NCT00225433Phase 4Completed20 enrolled2005

    Luteal Phase FSH in the IVF Poor Responder

    University of Pennsylvania

    Infertility

  • NCT00417183Phase 4Unknown300 enrolled2005

    Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation

    Eugonia

    Infertility

  • NCT01304511Completed711 enrolled2005

    Post-Marketing Surveillance of the Safety and Efficacy of Orgalutran (Ganirelix)®

    Organon and Co

    Fertilization in Vitro

  • NCT00985062Completed54 enrolled2004

    Mild Versus Conventional Ovarian Stimulation Treatment for In Vitro Fertilization

    Erasmus Medical Center

    Subfertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT00461422Phase 4Completed50 enrolled2004

    Early Follicular Supplementation of Ganirelix in IVF 2004

    The Baruch Padeh Medical Center, Poriya

    Infertility · IVF Treatment

  • NCT00635258Completed100 enrolled2004

    Administration of GnRH Antagonist to Oocyte Donation Recipients

    Centro Ginecologia y Obstetricia.

    Pregnancy · Embryo Implantation

  • NCT00417144Phase 4Unknown200 enrolled2003

    Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients

    Eugonia

    Polycystic Ovary Syndrome · Ovarian Hyperstimulation Syndrome

  • NCT00298025Phase 4Completed185 enrolled2003

    A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation

    EMD Serono

    Infertile Women Undergoing Assisted Reproductive Technology (ART)

  • NCT00417066Phase 4Completed270 enrolled2003

    Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders

    Eugonia

    Infertility · Premature Ovarian Failure

  • NCT00598208Phase 2Completed325 enrolled2003

    A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED)

    Organon and Co

    Fertilization

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT00988260Phase 2Completed266 enrolled2003

    Japanese Bridging Trial of Org 37462 (Study P05969)(COMPLETED)

    Organon and Co

    Controlled Ovarian Stimulation

  • NCT00702806Phase 2Completed99 enrolled2001

    Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)

    Organon and Co

    Infertility · In Vitro Fertilization

  • NCT00724789Completed2,066 enrolled2000

    Monitor the Incidence of Congenital Malformations in Infants of Women Who Have Been Treated With Ganirelix (Orgalutran®)(Study 38644)(P05966)(COMPLETED)

    Organon and Co

    Pregnancy · Neonates

Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when Ganirelix is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.